Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 731498, 6 pages
http://dx.doi.org/10.1155/2014/731498
Clinical Study

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation

1Department of Reproductive Center, Navy General Hospital, Fucheng Road, Beijing 100048, China
2Department of Obstetrics and Gynecology, Navy General Hospital, Fucheng Road, Beijing 100048, China

Received 26 May 2014; Revised 13 August 2014; Accepted 20 August 2014; Published 13 October 2014

Academic Editor: Małgorzata Kotula-Balak

Copyright © 2014 Ying Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Azziz, E. Carmina, D. Dewailly et al., “The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report,” Fertility and Sterility, vol. 91, no. 2, pp. 456–488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Fertility and Sterility, vol. 81, pp. 19–25, 2003. View at Google Scholar
  3. Q.-L. Wang, J. Song, S.-L. Chen et al., “Analysis of the clinical outcomes of IVF-ET treatment in infertile patients with polycystic ovary syndrome or polycystic ovaries,” Journal of Southern Medical University, vol. 29, no. 5, pp. 962–965, 2009. View at Google Scholar · View at Scopus
  4. World Health Organization, “Laboratory manual of the WHO for the examination of human semen and sperm-cervical mucus interaction,” Annali dell'Istituto Superiore di Sanità, vol. 37, no. 1, pp. 1–123, 2001. View at Google Scholar
  5. A. R. Folsom, K. K. Wu, E. Shahar, and C. E. Davis, “Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis,” Arteriosclerosis and Thrombosis, vol. 13, no. 12, pp. 1829–1836, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. W. S. Chan and M. E. Dixon, “The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications,” Thrombosis Research, vol. 121, no. 6, pp. 713–726, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. E. Grodnitskaya and M. A. Kurtser, “Homocysteine metabolism in polycystic ovary syndrome,” Gynecological Endocrinology, vol. 28, no. 3, pp. 186–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Aubard, N. Darodes, and M. Cantaloube, “Hyperhomocysteinemia and pregnancy—review of our present understanding and therapeutic implications,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 93, no. 2, pp. 157–165, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Sarandöl, Ö. Şafak, M. Dirican, and G. Uncu, “Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia,” Clinical Biochemistry, vol. 37, no. 11, pp. 990–996, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Pacchiarotti, M. A. Mohamed, G. Micara et al., “The possible role of hyperhomocysteinemia on IVF outcome,” Journal of Assisted Reproduction and Genetics, vol. 24, no. 10, pp. 459–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. Boxmeer, R. P. M. Steegers-Theunissen, J. Lindemans et al., “Homocysteine metabolism in the pre-ovulatory follicle during ovarian stimulation,” Human Reproduction, vol. 23, no. 11, pp. 2570–2576, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Henriquez, C. Calderon, M. Quezada et al., “Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI,” Journal of Cellular Physiology, vol. 226, no. 12, pp. 3278–3285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Westerlund, A. Antovic, O. Hovatta et al., “Changes in von Willebrand factor and ADAMTS13 during IVF,” Blood Coagulation and Fibrinolysis, vol. 22, no. 2, pp. 127–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. M. Jackson, “Factor X,” Progress in Hemostasis and Thrombosis, vol. 7, pp. 55–109, 1984. View at Google Scholar
  15. E.-G. V. Giardina, H. J. Chen, R. R. Sciacca, and L. E. Rabbani, “Dynamic variability of hemostatic and fibrinolytic factors in young women,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 6179–6184, 2004. View at Publisher · View at Google Scholar · View at Scopus